04025nam a2200421zi 45000010014000000030008000140050017000220070015000390080041000540200028000950200025001230220014001480400031001620720016001930720015002090720015002242450071002392640054003103360021003643370023003853380032004083650110004403660044005504900036005945000047006305050864006775160013015415201155015545450573027096500034032826500033033166500033033497000029033827000029034117000029034408560068034698560066035379781849841498UK-WkNB20210224000000.0cu||||||||||||210224e202112uuxxk    |s|||||||0|0 eng|d  a9781849841498 :c$85.00  a1849841497 :c$85.00  a2312-5098  aUK-WkNBbengcUK-WkNBerda 7aMJL2bicssc 7aHEA2ukslc 7aMJL2thema10aCOVID-19 /cEdited by Aurelie Fabre, John R. Hurst, Sheila Ramjug. 1aSheffield :bEuropean Respiratory Society,c2021.  atext2rdacontent  acomputer2rdamedia  aonline resource2rdacarrier  a02b85.00cUSDd00eThis price includes a tax elementhZ 85.00 0.00 85.00 0.00jGBkxxkmTEDITOR2onix-pt  b20211201cCS 20220208jGBkxxk2UK-WkNB0 aERS Monograph,x2312-5098 ;v94  aElectronic book text. Text (eye-readable).0 aRespiratory failure: a patient's perspective and clinical cases-- Epidemiology: global spread, risk factors for disease incidence, severity and mortality-- Historical perspective: other human coronavirus infectious diseases, SARS and MERS-- Drug repurposing and other strategies for rapid antiviral development: lessons from the early stage of the pandemic-- Can the immune system be targeted to treat COVID-19?-- Lung pathology-- Clinical features and acute management in adults-- Management in the ICU-- Clinical features and acute management in children-- Imaging-- Post-COVID-19 sequelae-- Post-COVID-19 rehabilitation-- Clinical trials during the pandemic-- research design and lessons-- Economic, physical and social determinants of health during lockdown: a call for renewed societal responses-- Vaccines: immunology regulation and clinical management.  aDocument  aThis Monograph provides a timely and valuable state-of-the-art summary for clinicians and scientists on this virus and its consequences to date. It is essential reading for all those involved in the care of people who are or who have been affected by COVID-19.bThe story of COVID-19 now seems so familiar: from the first reported case of a new respiratory infection in China in December 2019, to a pandemic that rapidly changed the world. Respiratory clinicians and scientists were at the forefront of delivering healthcare for people with COVID-19, leading efforts to understand this novel virus and disease, and developing and testing strategies to better prevent and treat it. These endeavours extended not only to the acute illness, but also to understanding the longer-term consequences. The pace of knowledge acquisition was rapid but is now maturing. This Monograph therefore provides a timely and valuable state-of-the-art summary for clinicians and scientists on our understanding of this virus and its consequences to date. It is essential reading for all those involved in the care of people who are or who have been affected by COVID-19.0 aAurelie Fabre is a Consultant Histopathologist ad Full Clinical Professor at St Vincent's University Hospital (Dublin, Ireland) and the School of Medicine at University College Dublin (Dublin), with a special interest in thoracic pathology (lung and cardiac). John R. Hurst is Professor Respiratory Medicine at University College London (London, UK). Sheila Ramjug is a Consultant Pulmonologist with a specialist interest in pulmonary vascular and interstitial lung disease, working in Wythenshawe Hospital, Manchester University NHS Foundation Trust (Manchester, UK). 7aRespiratory medicine.2bicssc 7aHealth and Wellbeing.2ukslc 7aRespiratory medicine.2thema1 aFabre, Aurelie,eeditor.1 aHurst, John R.,eeditor.1 aRamjug, Sheila,eeditor.4 uhttp://books.ersjournals.comx01zPublisher's corporate website4 uhttp://www.ersbookshop.comx01zPublisher's corporate website